Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5

IMPORTANCE: Outcome measures that are sensitive to disease progression are needed as clinical end points for future treatment trials in Stargardt disease. OBJECTIVE: To examine the incidence of atrophic lesions of the retinal pigment epithelium in patients with Stargardt disease as determined by fun...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JAMA Ophthalmol
Auteurs principaux: Strauss, Rupert W., Muñoz, Beatriz, Ho, Alex, Jha, Anamika, Michaelides, Michel, Mohand-Said, Saddek, Cideciyan, Artur V., Birch, David, Hariri, Amir H., Nittala, Muneeswar G., Sadda, SriniVas, Scholl, Hendrik P. N.
Format: Artigo
Langue:Inglês
Publié: American Medical Association 2017
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710205/
https://ncbi.nlm.nih.gov/pubmed/28542697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2017.1121
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires